A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients
Introduction Hexaxim is a hexavalent vaccine approved as primary and booster vaccination in infants 6 weeks and older, protecting against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and Haemophilus influenzae type b. Areas Covered To evaluate the immunogenicity and reactogenicity (saf...
Saved in:
Main Authors: | , , |
---|---|
格式: | 图书 |
出版: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
主题: | |
在线阅读: | Connect to this object online. |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
因特网
Connect to this object online.3rd Floor Main Library
索引号: |
A1234.567 |
---|---|
复印件 1 | 可用 |